Home › Trial NCT07415018
Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease
- Trial IDNCT07415018
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment40
- Start date2026-06-10
- ConditionsLeptomeningeal Disease
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.